𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparative study of the steady-state pharmacokinetics of immediate-release and controlled-release diltiazem tablets

✍ Scribed by O. R. Leeuwenkamp; H. W. Visscher; C. K. Mensink; J. H. G. Jonkman

Publisher
Springer
Year
1994
Tongue
English
Weight
472 KB
Volume
46
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Comparative steady state bioavailability
Comparative steady state bioavailability of conventional and controlled-release formulations of albuterol
✍ Mark L. Powell; Miryam Weisberger; Yvonne Dowdy; Richard Gural; Samson Symchowic πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 386 KB πŸ‘ 2 views

A new controlled-release (CR) dosage formulation of albuterol has been developed which is suitable for twice-a-day dosing. The present study was conducted in twelve healthy adult male volunteers to compare the steady state plasma levels obtained following repeated administration of a 4mg C R tablet

Relative bioavailability of oral sustain
Relative bioavailability of oral sustained-release and regular-release oxprenolol tablets at steady-state
✍ P. K. Gupta; J. K. C. Lim; A. R. Zoest; F. C. Lam; C. T. Hung πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 583 KB

## Abstract The relative bioavailability of a test sustained‐release (SR) oxprenolol tablet against an approved regular‐release (RR) tablet has been investigated at steady‐state. In a randomized two‐way crossover study, one tablet of 160mg SR oxprenolol once every 24 h and one tablet of 80 mg RR ox

THE RELATIVE BIOAVAILABILITY OF TWO MARK
THE RELATIVE BIOAVAILABILITY OF TWO MARKETED CONTROLLED RELEASE DILTIAZEM DOSAGE FORMS AT STEADY STATE IN HEALTHY VOLUNTEERS
✍ C. L. Lippert; T. Arumugham; V. O. Bhargava; M. Eller; S. J. Weir πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 472 KB πŸ‘ 2 views

This study was conducted to determine the relative bioavailability of Dilacorm XR capsules compared to CardizemD CD capsules at both low (180mgdPL) and high (540mgd-') dose levels. Trough and serial plasma samples were obtained and pharmacokinetic parameters were calculated from the steady state con